BPI-530616

N/A

Report date: 2024/07/16 11:54:58
NME

Base Information

Drug NameBPI-530616
Drug Alias NameBPI-530616
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMucosa-associated lymphoid tissue lymphoma translocation protein 1 inhibitors
TargetsMucosa-associated lymphoid tissue lymphoma translocation protein 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesBetta Pharmaceuticals Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBetta Pharmaceuticals Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A